LISTSERV at the University of Georgia
Menubar Imagemap
Home Browse Manage Request Manuals Register
Previous messageNext messagePrevious in topicNext in topicPrevious by same authorNext by same authorPrevious page (December 2001)Back to main SPSSX-L pageJoin or leave SPSSX-L (or change settings)ReplyPost a new messageSearchProportional fontNon-proportional font
Date:         Thu, 27 Dec 2001 13:51:02 -0500
Reply-To:     pjw@ACSU.BUFFALO.EDU
Sender:       "SPSSX(r) Discussion" <SPSSX-L@LISTSERV.UGA.EDU>
From:         pjw@ACSU.BUFFALO.EDU
Subject:      Re: How to calculate the sample size?
Comments: To: Christian Bautista <cbautista@namrid.sld.pe>
In-Reply-To:  <670440D45C5ED31180A6005004116476816201@namrid1.namrid.sld.pe>
Content-Type: text/plain

Quoting Christian Bautista <cbautista@namrid.sld.pe>:

> I want to evaluate two treatments and I going to do a > pharmaconekinetic analysis. So, I would like to know how to calculate > the sample size?. Is there any software? > > What kind of method I have to use my sample size? group sequencial > (proportions) or equivalence (proportions) or maybe other kind of > procedures.

If a "pharmaconekinetic" analysis involves repeated measures of variables potentially affected by the pharmacologic agent(s) under evaluation, then I would suggest

1) using some sort of hierarchical linear analysis software, so that you can treat time as a continuous variable, and avoid "missing data" problems;

2) designing the study to block on important nominal level antecedents (such as diagnosis, if that varies) and to match and/or counterbalance as much as possible on important continuous variables (such as baseline scores on the response variables that you are tracking, if applicable);

3) controlling in the data analysis for blocked and/or matched variables, plus any other antecedents that are known to have important effects on the response and/or outcome variables.

Controlling for known sources of error variation in the data analysis (especially in combination with conterbalancing in the design) can greatly decrease the sample size necessary to demonstrate that treatment effects exist, and it usually results in much more accurate estimates of their magnitudes. In order to take the implications of such control procedures appropriately into account in power estimates, think of the magnitude of treatment effects in terms of partial correlations -- the so-called (Sir Ronald)Fischer approach. You might also wish to think more in terms of putting confidence intervals around partial regression coefficients, and less in terms of statistical significance per se. (See Darlington's recent text for an excellent discussion of how to use this approach to kake decisions concerning sample size.)

Good luck with your study, Pow


Back to: Top of message | Previous page | Main SPSSX-L page